PCSK9-IN-22 (compound 29) is an orally active inhibitor of PCSK9 . PCSK9-IN-22 inhibits the interaction of the protein with LDLR in vivo.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PCSK9
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。